According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime.

For nearly 30 years, ZERO has been at the forefront of the battle against prostate cancer, providing essential resources, programs, services, and support to patients and families affected by this ...

A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan Borough Council, prostate cancer has been the most commonly diagnosed ...

Actinium announced ATNM-400, a novel, non-PSMA targeting, first in class radiotherapy for prostate cancer utilizing the Actinium-225 radioisotope. Initial preclinical data from ATNM-400 will be ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ...

Data for ABBV-969, a novel STEAP1/PSMA dual-targeted antibody-drug conjugate (ADC) in Phase 1 for advanced prostate cancer ... helps lay the scientific foundation for future innovation that ...

The primary approach for early detection of prostate cancer is through testing serum levels of prostate-specific antigen (PSA). However, given the limited cancer specificity of PSA, Proclarix® is ...

Prostate removal surgery is sometimes done to treat prostate cancer. Removing the prostate can cure prostate cancer and dramatically improve survival odds. However, there are side effects to ...

David Geier has repeatedly claimed that vaccines cause autism. Working alongside his father, he has published a number of ...

Cervical cancer is on the rise in the U.S., and while it is one of the most preventable cancers, recent research suggests that some women are not doing enough to catch the disease earlier.